Christoph Lawrence Bausch serves as CHIEF OPERATING OFFICER at SAB Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christoph Lawrence Bausch has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 1,800,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 3, 2026 | SABS | $0 | Award | 1,800,000 | $N/A | Discretionary |
Christoph Lawrence Bausch currently holds 1,800,000 shares of SAB Biotherapeutics, Inc. (SABS), valued at approximately $0. This represents their equity stake as CHIEF OPERATING OFFICER.
Based on SEC Form 4 filings, Christoph Lawrence Bausch has been a net neutral trader of SABS stock. They have purchased $0 and sold $0 worth of shares.
Christoph Lawrence Bausch's most recent insider trade was on Feb 3, 2026, when they sold 1,800,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted